Publication Cover
Neurological Research
A Journal of Progress in Neurosurgery, Neurology and Neurosciences
Volume 35, 2013 - Issue 9
62
Views
3
CrossRef citations to date
0
Altmetric
Original Article

GEMSP exerts a myelin-protecting role in the rat optic nerve

, , , &
Pages 903-911 | Received 20 Nov 2012, Accepted 19 May 2013, Published online: 18 Nov 2013
 

Abstract

Objectives: Chronic experimental autoimmune encephalomyelitis (EAE) was induced in rats to evaluate the potential protective effect of GEMSP, a mixture made up of fatty acids (FA), vitamins, and amino acids or their derivatives, linked to Poly-L-Lysine, on the myelin sheath of the optic nerve.

Methods: To evaluate the effects of GEMSP on the optic nerve, animals were divided into three experimental groups: (1) EAE rats treated with GEMSP; (2) EAE rats treated with 0·9% NaCl; and (3) control, non-EAE rats. Using electron microscopy, we investigated the possibility that this new drug candidate has a myelin-protective role.

Results: A marginally significant reduction in the thickness of the myelin around optic nerve medium-size axons (diameter between 0·8–1·3 μm) was found in EAE rats. Treatment of EAE rats with GEMSP ameliorated myelin damage. Significantly increased myelin thickness was found when animals in groups 2 and 3 were compared. However, the number of myelinated axons studied was not altered in groups 1 or 2 when compared to controls.

Discussion: Our results suggest that in a model of demyelination, GEMSP protects and enhances the formation of the myelin sheath of the optic nerve and therefore could be a potential drug candidate to reduce optic nerve pathogenesis in multiple sclerosis (MS).

This work has been supported by GEMACBIO (St Jean d'Illac, France), the Institut pour le Developpement de la Recherche en Pathologie Humaine et Therapeutique (IDRPHT) (Talence, France), Red de Terapia Celular de Castilla y León (Spain), Consejería de Educación de la Junta de Castilla y León (Spain) (Ref.: SA099A08), the INCYL-Federación de Cajas de Ahorro de Castilla y León (Spain) and Ministerio de Educación y Ciencia (Spain) (Ref.: SA F2007-62060), Grupos Consolidados del Gobierno Vasco (2010-2015), RETICS Red Patología Ocular RD07/0062, BIOEF08/ER/006. The technical assistance of Ms Belén Armario is gratefully acknowledged. The authors gratefully acknowledge Dr Jennifer Higginson for the English revision of the manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.